CA2378976A1 - Method of controlling body temperature while reducing shivering - Google Patents

Method of controlling body temperature while reducing shivering Download PDF

Info

Publication number
CA2378976A1
CA2378976A1 CA002378976A CA2378976A CA2378976A1 CA 2378976 A1 CA2378976 A1 CA 2378976A1 CA 002378976 A CA002378976 A CA 002378976A CA 2378976 A CA2378976 A CA 2378976A CA 2378976 A1 CA2378976 A1 CA 2378976A1
Authority
CA
Canada
Prior art keywords
group
pharmaceutically acceptable
acceptable salts
temperature
shivering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002378976A
Other languages
French (fr)
Other versions
CA2378976C (en
Inventor
Michael W. Dae
Timothy R. Machold
Wade A. Keller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zoll Circulation Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2378976A1 publication Critical patent/CA2378976A1/en
Application granted granted Critical
Publication of CA2378976C publication Critical patent/CA2378976C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/12—Devices for heating or cooling internal body cavities
    • A61F7/123—Devices for heating or cooling internal body cavities using a flexible balloon containing the thermal element
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017—Electrical control of surgical instruments
    • A61B2017/00022—Sensing or detecting at the treatment site
    • A61B2017/00084—Temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0054—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water
    • A61F2007/0056—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water for cooling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02—Compresses or poultices for effecting heating or cooling
    • A61F2007/0295—Compresses or poultices for effecting heating or cooling for heating or cooling or use at more than one temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/12—Devices for heating or cooling internal body cavities
    • A61F2007/126—Devices for heating or cooling internal body cavities for invasive application, e.g. for introducing into blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/36—General characteristics of the apparatus related to heating or cooling

Abstract

This invention is using a heat exchange device (240) in combination with an anti-shivering mechanism that temporar-ily reduces shivering for lowering the body temperature of a patient. Various anti-shivering agents are disclosed including dopamine receptor blockers, dopamine receptor agonists, opioid agonist antagonist analgesics, serotonin 5 HT1a agonists, and pharmaceuti-cally acceptable salts of any members of this group.

Claims (47)

1. A method for controlling the temperature of all or a portion of a patient's body to a temperature below its set point temperature, while reducing shivering, comprising the steps of: (a) sensing the temperature of all or a portion of the patient's body; (b) generating a signal based upon said sensed temperature; (c) controlling the temperature of all or a portion of the patient's body based upon said signal;
and (d) administering an anti-shivering mechanism to said patient.
2. The method of Claim 1 wherein said administering an anti-shivering mechanism comprises administering a therapeutically effective amount of an anti-shivering agent to said patient.
3. The method of Claim 1 wherein said administering an anti-shivering mechanism comprises applying warmth to the skin of said patient.
4. The method of Claim 1 wherein said administering an anti-shivering mechanism comprises administering a therapeutically effective amount of an anti-shivering agent to said patient and applying warmth to the skin of said patient.
5. The method of Claim 1 wherein the temperature controlling step (c) includes lowering the temperature below the set point temperature.
6. The method of Claim 1 wherein the temperature controlling step (c) includes raising the temperature from an initial temperature below the set point temperature.
7. The method of Claim 6 wherein the temperature controlling step (c) includes raising the temperature at a predetermined rate.
8. The method of Claim 6 wherein the temperature controlling step (c) includes maintaining the temperature at a stable temperature below the set point temperature.
9. The method of Claim 8 wherein the stable temperature is normothermia.
10. The method of Claim 1 wherein the temperature controlling step (c) includes placing a heat exchange device having a heat exchange region into the vascular system of the patient and controlling the temperature of the heat exchange region for a sufficient time to affect the temperature of all or a portion of the patient's body.
11. The method of Claim 10 wherein the heat exchange device is a catheter and the heat exchange region comprises a balloon on said catheter, the temperature of said balloon being controlled by the circulation of a heat exchange fluid through the interior of said balloon.
12. The method of Claim 2 wherein said anti-shivering agent is selected from the group consisting o~ dopamine receptor blockers; dopamine receptor agonists; .kappa.
opioid receptor agonists; opioid agonist-antagonist analgesics; serotonin 5HT1a receptor agonists; and their pharmaceutically acceptable salts.
13. The method of Claim 12 wherein said anti-shivering agent is selected from the group consisting of buspirone, ipsapirone, 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan.
14. The method of Claim 2 wherein said anti-shivering agent is a combination of agents selected from the group consisting of: dopamine receptor blockers; dopamine receptor agonists; .kappa. opioid receptor agonists; opioid agonist-antagonist analgesics; serotonin 5HT1a receptor agonists; and their pharmaceutically acceptable salts.
15. The method of Claim 14 wherein said anti-shivering agent is a combination of a .kappa.
opioid receptor agonist and an agent selected from the group consisting of:
dopamine receptor blockers; dopamine receptor agonists; and their pharmaceutically acceptable salts.
16. The method of Claim 15 wherein said .kappa. opioid receptor agonist is selected from the group consisting of: bremazocine: nalorphine; ketazocine; ethylketazocine;
tifluadom;
trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzene acetamide;
(5a,7a,8B)-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro(4,5)-dec-8-yl]benzene acetamide; and their pharmaceutically acceptable salts.
17. The method of Claim 15 wherein said dopamine receptor blocker is selected from the group consisting of phenothiazines and neuroleptic drugs, wherein said phenothiazines have the formula:

wherein R1 is selected from the group consisting of -H, halo, haloalkyl, alkyl and alkoxy; and R2 is selected from the group consisting of halo, an aliphatic group having a terminal tertiary amino nitrogen atom, an aliphatic group having a terminal piperidine substituent, and an aliphatic group having a piperazine substituent, and pharmaceutically acceptable salts thereof, and said neuroleptic drugs are selected from the group consisting of chlorprothixene, thiothixene, pimozide, penfluridol, loxapine, clozapine, sulpiride, haloperidol, disulfiram, and their pharmaceutically acceptable salts; and said dopamine receptor agonist is selected from the group consisting of amantadine, bromocriptine, piribidil, apomorphine, lisuride, pergolide, mesulergine, and their pharmaceutically acceptable salts.
18. The method of Claim 17 wherein said phenothiazine is selected from the group consisting of: chlorpromazine; triflupromazine; thioridazine; mesoridazine;
piperacetazine; fluphenazine; trifluoperazine; acetophenazine; carphenazine;
fluphenazine; perphenazine; prochlorperazine; and their pharmaceutically acceptable salts.
19. The method of Claim 18 wherein said phenothiazine is chlorpromazine, thorazine, or a pharmaceutically acceptable salt thereof.
20. The method of Claim 15 wherein said combination further comprises a mu opioid receptor antagonist or a pharmaceutically acceptable salt thereof.
21. The method of Claim 14 wherein said anti-shivering agent is a combination of a dopamine receptor blocker and an opioid agonist-antagonist analgesic; and their pharmaceutically acceptable salts.
22. The method of Claim 21 wherein said dopamine receptor blocker is a phenothiazine having the formula:

wherein R1 is selected from the group consisting of -H, halo, haloalkyl, alkyl and alkoxy; and R2 is selected from the group consisting of halo, an aliphatic group having a terminal tertiary amino nitrogen atom, an aliphatic group having a terminal piperidine substituent, and an aliphatic group having a piperazine substituent; and pharmaceutically acceptable salts thereof.
23. The method of Claim 22 wherein said phenothiazine is selected from the group consisting of: chlorpromazine; triflupromazine; thioridazine; mesoridazine;
piperacetazine; fluphenazine; trifluoperazine; acetophenazine; carphenazine;
fluphenazine; perphenazine; prochlorperazine; and their pharmaceutically acceptable salts.
24. The method of Claim 23 wherein said phenothiazine is chlorpromazine, thorazine or a pharmaceutically acceptable salt thereof.
25. The method of Claim 21 wherein said opioid agonist-antagonist analgesic is selected from the group consisting of: nalorphine; pentazocine; buprenorphine;
butorphanol;
nalbuphine; cyclazozine; dezozine; and nalorphone; and their pharmaceutically acceptable salts.
26. The method of Claim 25 wherein said opioid agonist-antagonist analgesic is nalbuphine and its pharmaceutically acceptable salts.
27. A method of controlling the temperature of a patient below the set point temperature comprising the steps of: (a) employing internal in vivo core temperature regulation;
and (b) administration of an anti-shivering mechanism.
28. The method of Claim 27 wherein said administering an anti-shivering mechanism comprises administering a therapeutically effective amount of an anti-shivering agent to said patient.
29. The method of Claim 27 wherein said administering an anti-shivering mechanism comprises applying warmth to the skin of said patient.
30. The method of Claim 27 wherein said administering an anti-shivering mechanism comprises administering a therapeutically effective amount of an anti-shivering agent to said patient and applying warmth to the skin of said patient.
31. The method of Claim 27 wherein the step of employing internal in vivo core temperature regulation comprises placing a heat exchange device in the blood vessels of the patient, said heat exchange device having a heat exchange region, said heat exchange region being in contact with the flowing blood of the patient; and controlling the temperature of the heat exchange region for a sufficient time to affect the temperature of the patient.
32. The method of Claim 31 wherein the heat exchange device is a catheter having a shaft for the circulation of heat exchange fluid therein, and said heat exchange region is a balloon; and said step of controlling the temperature of the heat exchange region includes circulation of heat exchange fluid through said shaft and through the interior of said balloon.
33. The method of Claim 28 wherein said anti-shivering agent is selected from the group consisting of: dopamine receptor blockers; dopamine receptor agonists; K
opioid receptor agonists; opioid agonist-antagonist analgesics; serotonin SHTIa receptor agonists; and their pharmaceutically acceptable salts.
34. The method of Claim 33 wherein said anti-shivering agent is selected from the group consisting of buspirone, ipsapirone, 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan.
35. The method of Claim 28 wherein said anti-shivering agent is a combination of agents selected from the group consisting of: dopamine receptor blockers; dopamine receptor agonists; K opioid receptor agonists; opioid agonist-antagonist analgesics;
serotonin SHTla receptor agonists; and their pharmaceutically acceptable salts.
36. The method of Claim 35 wherein said anti-shivering agent is a combination of a x opioid receptor agonist and an agent selected from the group consisting of:
dopamine receptor Mockers; dopamine receptor agonists; and their pharmaceutically acceptable salts.
37. The method of Claim 36 wherein said K opioid receptor agonist is selected from the group consisting of: bremazocine: nalorphine; ketazocine; ethylketazocine;
tifluadom;

traps-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzene acetamide;
(5a,7a,8B)-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro(4,5)-dec-8-yl]benzene acetamide; and their pharmaceutically acceptable salts.
38. The method of Claim 36 wherein said dopamine receptor blocker is selected from the group consisting of phenothiazines and neuroleptic drugs, wherein said phenothiazines have the formula:

wherein R1 is selected from the group consisting of -H, halo, haloalkyl, alkyl and alkoxy; and R2 is selected from the group consisting of halo, an aliphatic group having a terminal tertiary amino nitrogen atom, an aliphatic group having a terminal piperidine substituent, and an aliphatic group having a piperazine substituent, and pharmaceutically acceptable salts thereof, and said neuroleptic drugs are selected from the group consisting of chlorprothixene, thiothixene, pimozide, penfluridol, loxapine, clozapine, sulphide, haloperidol, disulfiram, and their pharmaceutically acceptable salts; and said dopamine receptor agonist is selected from the group consisting of amantadine, bromocriptine, piribidil, apomorphine, lisuride, pergolide, mesulergine, and their pharmaceutically acceptable salts.
39. The method of Claim 38 wherein said phenothiazine is selected from the group consisting of: chlorpromazine; triflupromazine; thioridazine; mesoridazine;
piperacetazine; fluphenazine; trifluoperazine; acetophenazine; carphenazine;
fluphenazine; perphenazine; prochlorperazine; and their pharmaceutically acceptable salts.
40. The method of Claim 39 wherein said phenothiazine is chlorpromazine, thorazine, or a pharmaceutically acceptable salt thereof.
41. The method of Claim 36 wherein said combination further comprises a mu opioid receptor antagonist or a pharmaceutically acceptable salt thereof.
42. The method of Claim 35 wherein said anti-shivering agent is a combination of a dopamine receptor Mocker and an opioid agonist-antagonist analgesic; and their pharmaceutically acceptable salts.
43 43. The method of Claim 42 wherein said dopamine receptor blocker is a phenothiazine having the formula:

wherein R1 is selected from the group consisting of -H, halo, haloalkyl, alkyl and alkoxy; and R2 is selected from the group consisting of halo, an aliphatic group having a terminal tertiary amino nitrogen atom, an aliphatic group having a terminal piperidine substituent, and an aliphatic group having a piperazine substituent; and pharmaceutically acceptable salts thereof.
44. The method of Claim 43 wherein said phenothiazine is selected from the group consisting of: chlorpromazine; triflupromazine; thioridazine; mesoridazine;
piperacetazine; fluphenazine; trifluoperazine; acetophenazine; carphenazine;
fluphenazine; perphenazine; prochlorperazine; and their pharmaceutically acceptable salts.
45. The method of Claim 44 wherein said phenothiazine is chlorpromazine, thorazine or a pharmaceutically acceptable salt thereof.
46. The method of Claim 42 wherein said opioid agonist-antagonist analgesic is selected from the group consisting of: nalorphine; pentazocine; buprenorphine;
butorphanol;
nalbuphine; cyclazozine; dezozine; and nalorphone; and their pharmaceutically acceptable salts.
47. The method of Claim 46 wherein said opioid agonist-antagonist analgesic is nalbuphine and its pharmaceutically acceptable salts.
CA2378976A 1999-08-11 2000-07-26 Method of controlling body temperature while reducing shivering Expired - Lifetime CA2378976C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/372,714 US6231594B1 (en) 1999-08-11 1999-08-11 Method of controlling body temperature while reducing shivering
US09/372,714 1999-08-11
PCT/US2000/020321 WO2001010323A1 (en) 1999-08-11 2000-07-26 Method of controlling body temperature while reducing shivering

Publications (2)

Publication Number Publication Date
CA2378976A1 true CA2378976A1 (en) 2001-02-15
CA2378976C CA2378976C (en) 2010-02-09

Family

ID=23469323

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2378976A Expired - Lifetime CA2378976C (en) 1999-08-11 2000-07-26 Method of controlling body temperature while reducing shivering

Country Status (9)

Country Link
US (4) US6231594B1 (en)
EP (1) EP1212000B1 (en)
JP (1) JP4787919B2 (en)
AT (1) ATE314831T1 (en)
AU (2) AU782277B2 (en)
CA (1) CA2378976C (en)
DE (1) DE60025362T2 (en)
ES (1) ES2256024T3 (en)
WO (1) WO2001010323A1 (en)

Families Citing this family (199)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096068A (en) 1998-01-23 2000-08-01 Innercool Therapies, Inc. Selective organ cooling catheter and method of using the same
US6231595B1 (en) 1998-03-31 2001-05-15 Innercool Therapies, Inc. Circulating fluid hypothermia method and apparatus
US6379378B1 (en) 2000-03-03 2002-04-30 Innercool Therapies, Inc. Lumen design for catheter
US7371254B2 (en) 1998-01-23 2008-05-13 Innercool Therapies, Inc. Medical procedure
US6702841B2 (en) * 1998-01-23 2004-03-09 Innercool Therapies, Inc. Method of manufacturing a heat transfer element for in vivo cooling
US6261312B1 (en) 1998-06-23 2001-07-17 Innercool Therapies, Inc. Inflatable catheter for selective organ heating and cooling and method of using the same
US7458984B2 (en) * 1998-01-23 2008-12-02 Innercool Therapies, Inc. System and method for inducing hypothermia with active patient temperature control employing catheter-mounted temperature sensor and temperature projection algorithm
US6312452B1 (en) 1998-01-23 2001-11-06 Innercool Therapies, Inc. Selective organ cooling catheter with guidewire apparatus and temperature-monitoring device
US6585752B2 (en) 1998-06-23 2003-07-01 Innercool Therapies, Inc. Fever regulation method and apparatus
US6464716B1 (en) 1998-01-23 2002-10-15 Innercool Therapies, Inc. Selective organ cooling apparatus and method
US6491039B1 (en) 1998-01-23 2002-12-10 Innercool Therapies, Inc. Medical procedure
US6251130B1 (en) 1998-03-24 2001-06-26 Innercool Therapies, Inc. Device for applications of selective organ cooling
US6383210B1 (en) 2000-06-02 2002-05-07 Innercool Therapies, Inc. Method for determining the effective thermal mass of a body or organ using cooling catheter
US6325818B1 (en) 1999-10-07 2001-12-04 Innercool Therapies, Inc. Inflatable cooling apparatus for selective organ hypothermia
US6471717B1 (en) * 1998-03-24 2002-10-29 Innercool Therapies, Inc. Selective organ cooling apparatus and method
US6974463B2 (en) 1999-02-09 2005-12-13 Innercool Therapies, Inc. System and method for patient temperature control employing temperature projection algorithm
US6719779B2 (en) 2000-11-07 2004-04-13 Innercool Therapies, Inc. Circulation set for temperature-controlled catheter and method of using the same
US6551349B2 (en) 1998-03-24 2003-04-22 Innercool Therapies, Inc. Selective organ cooling apparatus
US7291144B2 (en) 1998-03-31 2007-11-06 Innercool Therapies, Inc. Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation
US6602276B2 (en) 1998-03-31 2003-08-05 Innercool Therapies, Inc. Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation
US6905494B2 (en) 1998-03-31 2005-06-14 Innercool Therapies, Inc. Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing tissue protection
US6685732B2 (en) 1998-03-31 2004-02-03 Innercool Therapies, Inc. Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing microporous balloon
US6682551B1 (en) 1999-03-11 2004-01-27 Alsius Corporation Method and system for treating cardiac arrest using hypothermia
US6458150B1 (en) 1999-02-19 2002-10-01 Alsius Corporation Method and apparatus for patient temperature control
US6368304B1 (en) 1999-02-19 2002-04-09 Alsius Corporation Central venous catheter with heat exchange membrane
US6149670A (en) * 1999-03-11 2000-11-21 Alsius Corporation Method and system for treating cardiac arrest using hypothermia
US6520933B1 (en) 1998-04-21 2003-02-18 Alsius Corporation Central venous line cooling catheter having a spiral-shaped heat exchange member
US6645234B2 (en) 1998-04-21 2003-11-11 Alsius Corporation Cardiovascular guiding catheter with heat exchange properties and methods of use
US8128595B2 (en) * 1998-04-21 2012-03-06 Zoll Circulation, Inc. Method for a central venous line catheter having a temperature control system
US6126684A (en) 1998-04-21 2000-10-03 The Regents Of The University Of California Indwelling heat exchange catheter and method of using same
US6338727B1 (en) 1998-08-13 2002-01-15 Alsius Corporation Indwelling heat exchange catheter and method of using same
US6673098B1 (en) * 1998-08-24 2004-01-06 Radiant Medical, Inc. Disposable cassette for intravascular heat exchange catheter
US6620189B1 (en) 2000-02-28 2003-09-16 Radiant Medical, Inc. Method and system for control of a patient's body temperature by way of a transluminally insertable heat exchange catheter
US6146411A (en) 1998-12-24 2000-11-14 Alsius Corporation Cooling system for indwelling heat exchange catheter
US6869440B2 (en) * 1999-02-09 2005-03-22 Innercool Therapies, Inc. Method and apparatus for patient temperature control employing administration of anti-shivering agents
US7914564B2 (en) * 1999-02-09 2011-03-29 Innercool Therapies, Inc. System and method for patient temperature control employing temperature projection algorithm
US6830581B2 (en) * 1999-02-09 2004-12-14 Innercool Therspies, Inc. Method and device for patient temperature control employing optimized rewarming
US6719724B1 (en) 1999-02-19 2004-04-13 Alsius Corporation Central venous line catheter having multiple heat exchange elements and multiple infusion lumens
US6299599B1 (en) * 1999-02-19 2001-10-09 Alsius Corporation Dual balloon central venous line catheter temperature control system
US6585692B1 (en) * 1999-02-19 2003-07-01 Alsius Corporation Method and system for patient temperature management and central venous access
US6554797B1 (en) 1999-02-19 2003-04-29 Alsius Corporation Method and system for patient temperature management and central venous access
US6460544B1 (en) 1999-03-11 2002-10-08 Alsius Corporation Method and apparatus for establishing and maintaining therapeutic hypothemia
US6165207A (en) 1999-05-27 2000-12-26 Alsius Corporation Method of selectively shaping hollow fibers of heat exchange catheter
US6231594B1 (en) * 1999-08-11 2001-05-15 Radiant Medical, Inc. Method of controlling body temperature while reducing shivering
US6726710B2 (en) 1999-08-16 2004-04-27 Alsius Corporation Method and system for treating cardiac arrest using hypothermia
AU4713601A (en) * 1999-12-07 2001-06-18 Alsius Corporation Method and system for treating stroke using hypothermia
WO2001043661A2 (en) * 1999-12-14 2001-06-21 Radiant Medical, Inc. Method for reducing myocardial infarct by applicaton of intravascular hypothermia
US6648906B2 (en) 2000-04-06 2003-11-18 Innercool Therapies, Inc. Method and apparatus for regulating patient temperature by irrigating the bladder with a fluid
US6592612B1 (en) * 2000-05-04 2003-07-15 Cardeon Corporation Method and apparatus for providing heat exchange within a catheter body
US6726708B2 (en) 2000-06-14 2004-04-27 Innercool Therapies, Inc. Therapeutic heating and cooling via temperature management of a colon-inserted balloon
US6530945B1 (en) 2000-11-28 2003-03-11 Alsius Corporation System and method for controlling patient temperature
US6719723B2 (en) * 2000-12-06 2004-04-13 Innercool Therapies, Inc. Multipurpose catheter assembly
US6450987B1 (en) 2001-02-01 2002-09-17 Innercool Therapies, Inc. Collapsible guidewire lumen
US6582457B2 (en) * 2001-02-15 2003-06-24 Radiant Medical, Inc. Method of controlling body temperature while reducing shivering
US6544282B1 (en) 2001-02-21 2003-04-08 Radiant Medical, Inc. Inhibition of platelet activation, aggregation and/or adhesion by hypothermia
US6451045B1 (en) * 2001-02-22 2002-09-17 Alsius Corporation Heat exchange catheter having a helically wrapped heat exchanger
US6641603B2 (en) 2001-04-13 2003-11-04 Alsius Corporation Heat exchange catheter having helically wound reinforcement
US6709448B2 (en) 2001-04-13 2004-03-23 Alsius Corporation Open core heat exchange catheter, system and method
US6641602B2 (en) * 2001-04-13 2003-11-04 Alsius Corporation Method and device including a colo-rectal heat exchanger
US6752786B2 (en) * 2001-05-31 2004-06-22 Radiant Medical, Inc. Moving heat exchange catheter system
US6706060B2 (en) * 2001-06-05 2004-03-16 Alsius Corporation Heat exchange catheter
US6679906B2 (en) 2001-07-13 2004-01-20 Radiant Medical, Inc. Catheter system with on-board temperature probe
US6692519B1 (en) * 2001-08-06 2004-02-17 Radiant Medical, Inc. Use of endovascular hypothermia in organ and/or tissue transplantations
US20070213793A1 (en) * 2001-08-06 2007-09-13 Radiant Medical, Inc. Use of endovascular hypothermia in organ and/or tissue transplantations
AU2002331032A1 (en) * 2001-08-09 2003-02-24 Innercool Therapies, Inc. Method and device for patient temperature control employing optimized rewarming
CA2454607C (en) * 2001-08-15 2010-04-06 Innercool Therapies, Inc. System and method for patient temperature control employing temperature projection algorithm
WO2003015672A1 (en) * 2001-08-15 2003-02-27 Innercool Therapies, Inc. Method and apparatus for patient temperature control employing administration of anti-shivering
US20030065922A1 (en) * 2001-09-28 2003-04-03 Fredlund John R. System and method of authenticating a digitally captured image
US6800068B1 (en) 2001-10-26 2004-10-05 Radiant Medical, Inc. Intra-aortic balloon counterpulsation with concurrent hypothermia
US6572640B1 (en) * 2001-11-21 2003-06-03 Alsius Corporation Method and apparatus for cardiopulmonary bypass patient temperature control
US7077825B1 (en) * 2002-01-16 2006-07-18 Radiant Medical, Inc. Method for gastric cooling using balloon catheter
US20160193078A1 (en) 2002-01-16 2016-07-07 Zoll Circulation, Inc. Apparatus and Method Of Gastric Cooling Using Balloon Catheter
US7288109B2 (en) 2002-04-04 2007-10-30 Innercool Therapies. Inc. Method of manufacturing a heat transfer element for in vivo cooling without undercuts
US6685733B1 (en) 2002-04-10 2004-02-03 Radiant Medical, Inc. Methods and systems for reducing substance-induced renal damage
US6866638B2 (en) 2002-08-12 2005-03-15 Radiant Medical, Inc. Temperature sensing system with retrograde sensor
US7186222B1 (en) 2002-09-10 2007-03-06 Radiant Medical, Inc. Vascular introducer with temperature monitoring probe and systems for endovascular temperature control
US20040087606A1 (en) * 2002-11-01 2004-05-06 Voorhees Marc E. Shivering suppression during cooling to lower body temperature
CA2411569A1 (en) * 2002-11-12 2004-05-12 Ross E. Mantle Medical device for the extravascular recirculation of fluid in body cavities at controlled temperature and pressure
US7319090B2 (en) * 2002-11-27 2008-01-15 University Of North Carolina At Chapel Hill Methods of treating cerebral ischemia
US7278984B2 (en) * 2002-12-31 2007-10-09 Alsius Corporation System and method for controlling rate of heat exchange with patient
EP1596824A4 (en) * 2003-02-04 2011-11-23 Chrysalis Tech Inc Aerosol formulations and aerosol delivery of buspirone, buprenorphine, triazolam, cyclobenzaprine and zolpidem
US20040162284A1 (en) * 2003-02-19 2004-08-19 Harris Herbert W. Method of lowering body temperature with (S) tofisopam
US20040167466A1 (en) * 2003-02-21 2004-08-26 Drasler William J. Delivering cooled fluid to sites inside the body
US20040167467A1 (en) * 2003-02-21 2004-08-26 Kent Harrison Delivering cooled fluid to sites inside the body
US7300453B2 (en) * 2003-02-24 2007-11-27 Innercool Therapies, Inc. System and method for inducing hypothermia with control and determination of catheter pressure
US7104985B2 (en) * 2003-03-06 2006-09-12 Martinelli Michael A Apparatus and method for causing selective necrosis of abnormal cells
WO2004083797A2 (en) * 2003-03-14 2004-09-30 Thermosurgery Technologies, Inc. Hyperthermia treatment system
US7758623B2 (en) * 2003-03-17 2010-07-20 The Board Of Trustees Of The Leland Stanford Junior University Transesophageal heat exchange catheter for cooling of the heart
US20040199114A1 (en) * 2003-04-01 2004-10-07 Alsius Corporation Intravascular heat exchange catheter with tissue preservative
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
US20040215163A1 (en) * 2003-04-28 2004-10-28 Walker Blair D. Intravascular heat exchange catheter with multiple coolant inlet holes to balloon
US6893454B2 (en) * 2003-04-28 2005-05-17 Alsius Corporation Intrarectal heat exchange catheter
NZ527142A (en) * 2003-07-23 2006-03-31 Douglas Pharmaceuticals Ltd A stable suspension formulation
US7361186B2 (en) * 2003-08-25 2008-04-22 Medivance, Incorporated Active body cooling with vasodilation to reduce body temperature
US7122047B2 (en) * 2003-11-14 2006-10-17 The Board Of Trustees Of The Leland Stanford Junior University Controlled heat transfer with mammalian bodies
US7326195B2 (en) * 2003-11-18 2008-02-05 Boston Scientific Scimed, Inc. Targeted cooling of tissue within a body
US20050159728A1 (en) * 2004-01-15 2005-07-21 Thomas Medical Products, Inc. Steerable sheath
US8100123B2 (en) * 2004-01-22 2012-01-24 Thermocure, Inc. Respiratory system for inducing therapeutic hypothermia
US20050267176A1 (en) * 2004-02-18 2005-12-01 Sepracor Inc. Dopamine-agonist combination therapy for improving sleep quality
JP4520183B2 (en) * 2004-03-09 2010-08-04 Ｈｏｙａ株式会社 Ultrasound endoscope and multi-lumen tube for ultrasound endoscope
US7959657B1 (en) * 2004-07-07 2011-06-14 Harsy Douglas R Portable thermal therapeutic apparatus and method
US20060025840A1 (en) * 2004-08-02 2006-02-02 Martin Willard Cooling tissue inside the body
US20060136023A1 (en) * 2004-08-26 2006-06-22 Dobak John D Iii Method and apparatus for patient temperature control employing administration of anti-shivering agents
US8353942B2 (en) 2004-09-16 2013-01-15 Thomas Lad Merrill Cooling guide catheter and associated method of use
US20060058859A1 (en) * 2004-09-16 2006-03-16 Merrill Thomas L Cooling catheter and method with adjunctive therapy capability
US20060064146A1 (en) * 2004-09-17 2006-03-23 Collins Kenneth A Heating/cooling system for indwelling heat exchange catheter
US7070612B1 (en) 2005-02-23 2006-07-04 Alsius Corporation System and method for bringing hypothermia rapidly onboard
US20060190062A1 (en) * 2005-02-23 2006-08-24 Worthen William J System and method for reducing shivering when using external cooling pads
US20060190066A1 (en) * 2005-02-23 2006-08-24 Worthen William J System and method for bringing hypothermia rapidly onboard
US7425216B2 (en) * 2005-03-01 2008-09-16 Alsius Corporation System and method for treating cardiac arrest and myocardial infarction
US7892269B2 (en) * 2005-04-18 2011-02-22 Zoll Circulation, Inc. External heat exchange pad for patient
US20060276864A1 (en) * 2005-06-03 2006-12-07 Alsius Corporation Systems and methods for sensing patient temperature in temperature management system
US20060293732A1 (en) * 2005-06-27 2006-12-28 Collins Kenneth A Thermoelectric cooler (TEC) heat exchanger for intravascular heat exchange catheter
WO2007002946A2 (en) 2005-06-29 2007-01-04 Radiant Medical, Inc. Devices, systems and methods for rapid endovascular cooling
US7181927B2 (en) 2005-07-01 2007-02-27 Alsius Corporation Primary heat exchanger for patient temperature control
US7951182B2 (en) * 2005-07-14 2011-05-31 Zoll Circulation, Inc. System and method for leak detection in external cooling pad
US20070093697A1 (en) * 2005-10-21 2007-04-26 Theranova, Llc Method and apparatus for detection of right to left shunting in the cardiopulmonary vasculature
US20180311071A1 (en) 2005-10-21 2018-11-01 Daniel R. BURNETT Method and apparatus for peritoneal oxygenation
US7850723B1 (en) * 2005-11-28 2010-12-14 Innercool Therapies, Inc. Method and apparatus for patient temperature control employing titration of therapy using EEG signals
US20070150033A1 (en) * 2005-12-22 2007-06-28 Cherlin Johnson Cooling blanket
US20070225781A1 (en) * 2006-03-21 2007-09-27 Nidus Medical, Llc Apparatus and methods for altering temperature in a region within the body
US20060258422A1 (en) * 2006-04-18 2006-11-16 Walker Jay S Methods and apparatus for free play mode operation of gaming devices
US9211212B2 (en) 2006-04-20 2015-12-15 Cerêve, Inc. Apparatus and method for modulating sleep
US8425583B2 (en) 2006-04-20 2013-04-23 University of Pittsburgh—of the Commonwealth System of Higher Education Methods, devices and systems for treating insomnia by inducing frontal cerebral hypothermia
US11684510B2 (en) 2006-04-20 2023-06-27 University of Pittsburgh—of the Commonwealth System of Higher Education Noninvasive, regional brain thermal stimuli for the treatment of neurological disorders
US9492313B2 (en) 2006-04-20 2016-11-15 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Method and apparatus of noninvasive, regional brain thermal stimuli for the treatment of neurological disorders
US7822485B2 (en) 2006-09-25 2010-10-26 Zoll Circulation, Inc. Method and apparatus for spinal cooling
US7867266B2 (en) 2006-11-13 2011-01-11 Zoll Circulation, Inc. Temperature management system with assist mode for use with heart-lung machine
US7892270B2 (en) * 2006-11-21 2011-02-22 Zoll Circulation Inc. Temperature management system and method for burn patients
US8353893B2 (en) 2007-03-07 2013-01-15 Zoll Circulation, Inc. System and method for rapidly cooling cardiac arrest patient
WO2008124643A1 (en) * 2007-04-05 2008-10-16 Velomedix, Inc. Device and method for safe access to a body cavity
EP2155300A1 (en) 2007-04-05 2010-02-24 Velomedix, Inc Automated therapy system and method
US9737692B2 (en) 2007-05-18 2017-08-22 Zoll Circulation, Inc. System and method for effecting non-standard fluid line connections
CA2693774A1 (en) * 2007-07-09 2009-01-15 Velomedix, Inc. Hypothermia devices and methods
US8475509B2 (en) * 2007-08-09 2013-07-02 Zoll Circulation, Inc. Devices and methods for using endovascular cooling to treat septic shock and other disorders
WO2009040744A2 (en) * 2007-09-24 2009-04-02 Jetprep Ltd. Virtual channel enabling device for use in endoscopic instrument insertion and body cavity cleansing
EP3677228A1 (en) 2007-10-12 2020-07-08 Medivance Incorporated Improved system for patient temperature control
WO2009065138A1 (en) * 2007-11-16 2009-05-22 Medivance Incorporated Patient temperature response control system and method
WO2009076399A2 (en) 2007-12-11 2009-06-18 Theravance, Inc. Aminotetralin compounds as mu opioid receptor antagonists
TWI412360B (en) 2007-12-11 2013-10-21 Theravance Inc 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
DE102008013860A1 (en) * 2008-03-12 2009-09-24 Siemens Aktiengesellschaft Catheter device for treatment of septum of heart, has coupling device arranged at proximal end in proximity of catheter tip to transport and position occluder, where sensor is provided in area of catheter tip for imaging
JP5676455B2 (en) * 2008-10-08 2015-02-25 ベッドロック・インヴェンションズ・エルエルシー Apparatus for measuring and processing shivering (vibration) during temperature control for treatment and temperature management system for treatment
AU2009313320A1 (en) * 2008-11-07 2010-05-14 Velomedix, Inc. Devices and methods for monitoring core temperature and an intraperitoneal parameter
CN102245564B (en) 2008-12-10 2015-04-01 施万生物制药研发Ip有限责任公司 Crystalline forms of a 3-carboxypropyl-aminotetralin compound
EP2393460A4 (en) * 2009-02-06 2012-06-27 Velomedix Inc Method and apparatus for inducing therapeutic hypothermia
US8608696B1 (en) 2009-02-24 2013-12-17 North Carolina State University Rapid fluid cooling devices and methods for cooling fluids
US9301871B2 (en) 2009-02-26 2016-04-05 Advanced Cooling Therapy, Inc. Devices and methods for controlling patient temperature
US9622909B2 (en) 2009-02-26 2017-04-18 Advanced Cooling Therapy, Inc. Devices and methods for controlling patient temperature
WO2012006625A2 (en) 2010-07-09 2012-01-12 Velomedix, Inc. Method and apparatus for pressure measurement
US8895622B2 (en) 2011-04-12 2014-11-25 Revogenex Ireland Ltd. Intravenous administration of tramadol
US10736889B2 (en) 2011-04-29 2020-08-11 Rutgers, The State University Of New Jersey Method of treating dyskinesia
US9918980B2 (en) 2011-04-29 2018-03-20 Rutgers, The State University Of New Jersey Method of treating dyskinesia
EP2736581A4 (en) 2011-07-25 2015-11-04 Neurosave Inc Non-invasive systems, devices, and methods for selective brain cooling
US9283110B2 (en) 2011-09-20 2016-03-15 Zoll Circulation, Inc. Patient temperature control catheter with outer sleeve cooled by inner sleeve
US9314370B2 (en) 2011-09-28 2016-04-19 Zoll Circulation, Inc. Self-centering patient temperature control catheter
US10045881B2 (en) 2011-09-28 2018-08-14 Zoll Circulation, Inc. Patient temperature control catheter with helical heat exchange paths
US9259348B2 (en) 2011-09-28 2016-02-16 Zoll Circulation, Inc. Transatrial patient temperature control catheter
US8888832B2 (en) 2011-09-28 2014-11-18 Zoll Circulation, Inc. System and method for doubled use of patient temperature control catheter
US9241827B2 (en) 2012-09-28 2016-01-26 Zoll Circulation, Inc. Intravascular heat exchange catheter with multiple spaced apart discrete coolant loops
US9801756B2 (en) 2012-09-28 2017-10-31 Zoll Circulation, Inc. Intravascular heat exchange catheter and system with RFID coupling
US9433528B2 (en) 2012-09-28 2016-09-06 Zoll Circulation, Inc. Intravascular heat exchange catheter with rib cage-like coolant path
US9717625B2 (en) 2012-09-28 2017-08-01 Zoll Circulation, Inc. Intravascular heat exchange catheter with non-round coiled coolant path
US9278023B2 (en) 2012-12-14 2016-03-08 Zoll Circulation, Inc. System and method for management of body temperature
ES2868181T3 (en) 2013-01-02 2021-10-21 Ebb Therapeutics Inc Systems to improve sleep
EP2983629B1 (en) * 2013-04-10 2022-06-08 Zoll Circulation, Inc. Detecting and responding to preshivering
CA2910069A1 (en) 2013-05-20 2014-11-27 Stryker Corporation Thermal control system
US10238831B2 (en) 2013-09-08 2019-03-26 Qool Therapeutics, Inc. Temperature measurement and feedback for therapeutic hypothermia
US9474644B2 (en) 2014-02-07 2016-10-25 Zoll Circulation, Inc. Heat exchange system for patient temperature control with multiple coolant chambers for multiple heat exchange modalities
US11033424B2 (en) 2014-02-14 2021-06-15 Zoll Circulation, Inc. Fluid cassette with tensioned polymeric membranes for patient heat exchange system
US10792185B2 (en) 2014-02-14 2020-10-06 Zoll Circulation, Inc. Fluid cassette with polymeric membranes and integral inlet and outlet tubes for patient heat exchange system
US10500088B2 (en) 2014-02-14 2019-12-10 Zoll Circulation, Inc. Patient heat exchange system with two and only two fluid loops
CN106573101B (en) 2014-08-14 2020-02-11 梅迪万斯股份有限公司 System and method for extracorporeal blood temperature control
JP6656259B2 (en) * 2014-10-15 2020-03-04 ブレインクール アーベー Apparatus and method for lowering a patient's core body temperature for hypothermic treatment
US9784263B2 (en) 2014-11-06 2017-10-10 Zoll Circulation, Inc. Heat exchange system for patient temperature control with easy loading high performance peristaltic pump
US11359620B2 (en) 2015-04-01 2022-06-14 Zoll Circulation, Inc. Heat exchange system for patient temperature control with easy loading high performance peristaltic pump
WO2016123241A1 (en) * 2015-01-27 2016-08-04 Cerêve, Inc. Method and apparatuses for modulating sleep by chemical activation of temperature receptors
JP6787903B2 (en) 2015-01-27 2020-11-18 メディヴァンス インコーポレイテッドＭｅｄｉｖａｎｃｅ，Ｉｎｃ． Improved medical pads and systems for hyperthermia
EP3261593B1 (en) 2015-02-23 2021-11-03 Qool Therapeutics, Inc. Systems and methods for endotracheal delivery of frozen particles
US10537465B2 (en) 2015-03-31 2020-01-21 Zoll Circulation, Inc. Cold plate design in heat exchanger for intravascular temperature management catheter and/or heat exchange pad
US11213423B2 (en) 2015-03-31 2022-01-04 Zoll Circulation, Inc. Proximal mounting of temperature sensor in intravascular temperature management catheter
US10022265B2 (en) 2015-04-01 2018-07-17 Zoll Circulation, Inc. Working fluid cassette with hinged plenum or enclosure for interfacing heat exchanger with intravascular temperature management catheter
EP3359071A4 (en) * 2015-10-06 2019-06-05 Minnetronix Inc. Devices and methods for providing focal cooling to the brain and spinal cord
US9980900B2 (en) 2015-12-22 2018-05-29 Revogenex Ireland Ltd Intravenous administration of tramadol
US9693949B1 (en) 2015-12-22 2017-07-04 Revogenex Ireland Ltd Intravenous administration of tramadol
US10022321B2 (en) 2016-06-30 2018-07-17 Revogenex Ireland Ltd. Intravenous administration of tramadol
US11058572B2 (en) 2016-10-11 2021-07-13 Stryker Corporation Thermal control system
US11324673B2 (en) 2016-11-18 2022-05-10 Miraki Innovation Think Tank Llc Cosmetic appearance of skin
US10993829B2 (en) 2016-11-23 2021-05-04 Stryker Corporation Thermal system
US10561528B2 (en) * 2016-12-30 2020-02-18 Zoll Circulation, Inc. Fluid-circulating catheters useable for endovascular heat exchange
US11116657B2 (en) 2017-02-02 2021-09-14 Zoll Circulation, Inc. Devices, systems and methods for endovascular temperature control
US11337851B2 (en) 2017-02-02 2022-05-24 Zoll Circulation, Inc. Devices, systems and methods for endovascular temperature control
US11185440B2 (en) 2017-02-02 2021-11-30 Zoll Circulation, Inc. Devices, systems and methods for endovascular temperature control
SG11201908076TA (en) * 2017-03-01 2019-09-27 Arctic Fox Biomedical Inc Cryotherapies
MX2019011995A (en) 2017-04-05 2020-01-20 Miraki Innovation Think Tank Llc Point of delivery cold slurry generation.
JP7085762B2 (en) 2017-04-05 2022-06-17 ミラキ イノベーション シンク タンク エルエルシー Cold slurry confinement
US10500342B2 (en) 2017-08-21 2019-12-10 Miraki Innovation Think Tank Llc Cold slurry syringe
US10849787B2 (en) * 2017-09-15 2020-12-01 Rohit Khanna Method and apparatus for treating the brain and/or spinal cord using a catheter
US20230142802A1 (en) * 2020-02-04 2023-05-11 Zoll Circulation, Inc. Determining a value indicative of a thermoregulatory activity of a patient using a temperature management system
US11612514B2 (en) 2020-03-03 2023-03-28 Eric Matthew Jaeger Methods and devices for thermoregulation of core body temperature through application of near infrared radiation and localized thermal transfer on skin surfaces

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3425419A (en) * 1964-08-08 1969-02-04 Angelo Actis Dato Method of lowering and raising the temperature of the human body
US3618602A (en) * 1969-08-28 1971-11-09 Robert F Shaw Liquid infusion infiltration detection apparatus and method
GB2101114B (en) 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FR2567754B1 (en) 1984-07-20 1987-05-29 Cortial THINAPEUTIC APPLICATION OF AMINOMETHYLENE-2 INDANEDIONES-1,3 SUBSTITUTED ON NITROGEN
US4758562A (en) 1985-12-18 1988-07-19 Temple University Of The Commonwealth System Of Higher Education Method for inducing hypothermia and/or poikilothermia
AU606811B2 (en) * 1988-08-30 1991-02-14 Spectramed, Inc. Apparatus and method for determining cardiac output by thermodilution without injection
US4941475A (en) * 1988-08-30 1990-07-17 Spectramed, Inc. Thermodilution by heat exchange
US5120713A (en) 1990-09-10 1992-06-09 Applied Research Systems Ars Holding N.V. Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
US5073688A (en) * 1991-04-01 1991-12-17 Mccormack William C Body temperature responsive transport warming blanket
US6033383A (en) 1996-12-19 2000-03-07 Ginsburg; Robert Temperature regulating catheter and methods
US5837003A (en) 1993-02-10 1998-11-17 Radiant Medical, Inc. Method and apparatus for controlling a patient's body temperature by in situ blood temperature modification
US5486208A (en) 1993-02-10 1996-01-23 Ginsburg; Robert Method and apparatus for controlling a patient's body temperature by in situ blood temperature modification
US5510490A (en) 1994-01-11 1996-04-23 Council Of Scientific & Industrial Research Process for the preparation of epibatidine
US5716386A (en) * 1994-06-27 1998-02-10 The Ohio State University Non-invasive aortic impingement and core and cerebral temperature manipulation
US5486204A (en) * 1994-09-20 1996-01-23 University Of Texas Health Science Center Houston Method of treating a non-penetrating head wound with hypothermia
US6156057A (en) * 1995-08-12 2000-12-05 Fox; James Allan Method for inducing hypothermia
US5863934A (en) 1995-09-21 1999-01-26 Amy F. T. Arnsten Use of lofexidine in the treatment of behavioral disorders
US6206004B1 (en) * 1996-12-06 2001-03-27 Comedicus Incorporated Treatment method via the pericardial space
US5879329A (en) 1997-01-22 1999-03-09 Radiant Medical, Inc. Infusion systems and methods for introducing fluids into the body within a desired temperature range
US6843800B1 (en) 1998-01-23 2005-01-18 Innercool Therapies, Inc. Patient temperature regulation method and apparatus
US6231595B1 (en) * 1998-03-31 2001-05-15 Innercool Therapies, Inc. Circulating fluid hypothermia method and apparatus
US6410554B1 (en) * 1998-03-23 2002-06-25 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia
US6420137B1 (en) 1998-11-25 2002-07-16 American Home Products Corporation Nucleic acid encoding human neurotensin subtype 2 receptor
US6299599B1 (en) 1999-02-19 2001-10-09 Alsius Corporation Dual balloon central venous line catheter temperature control system
US6231594B1 (en) 1999-08-11 2001-05-15 Radiant Medical, Inc. Method of controlling body temperature while reducing shivering

Also Published As

Publication number Publication date
US20040073280A1 (en) 2004-04-15
ATE314831T1 (en) 2006-02-15
DE60025362D1 (en) 2006-03-30
AU2005222530B9 (en) 2009-07-23
JP2003506385A (en) 2003-02-18
WO2001010323A1 (en) 2001-02-15
ES2256024T3 (en) 2006-07-16
DE60025362T2 (en) 2006-09-28
CA2378976C (en) 2010-02-09
EP1212000A1 (en) 2002-06-12
US6572638B1 (en) 2003-06-03
EP1212000B1 (en) 2006-01-04
US6702839B1 (en) 2004-03-09
AU782277B2 (en) 2005-07-14
AU2005222530A1 (en) 2005-11-10
AU2005222530B2 (en) 2009-06-04
AU6377400A (en) 2001-03-05
JP4787919B2 (en) 2011-10-05
US6231594B1 (en) 2001-05-15
EP1212000A4 (en) 2002-10-25
US7008444B2 (en) 2006-03-07

Similar Documents

Publication Publication Date Title
CA2378976A1 (en) Method of controlling body temperature while reducing shivering
JP2003506385A5 (en)
EP2216018B1 (en) Transdermal delivery systems
JP2002534508A5 (en)
US6573282B1 (en) Peripherally active anti-hyperalgesic opiates
NO20023012D0 (en) Device for delivery of drug with antiprogestin properties
JP2011500658A5 (en)
CA2526361A1 (en) Amide derivative
PT923548E (en) 4-AMINOETHOXY-INDOLES AS DOPAMINAE D2 AGONISTS AS 5HT1A LIGANDS
AU2001260723A1 (en) Warmer for medical treatment and its control method
US20180193464A1 (en) Compositions and methods for injection of a biodegradable polymer-based delivery system
EP1236719A4 (en) Novel heterocyclic compounds and salts thereof and medicinal use of the same
EP3096721A2 (en) Devices configured to provide treatment at an abreu brain thermal tunnel
CN105662674B (en) A kind of self-adjustable foreskin postoperative protector
JP2005519885A5 (en)
FR2829381B1 (en) DEVICE INTENDED TO ELIMINATE NOCTURNAL SNORING IN A PATIENT SUBJECT TO SLEEP APNEA
JPWO2004041270A1 (en) 3-methyl-1-phenyl-2-pyrazolin-5-one-containing percutaneous absorption preparation
US4758562A (en) Method for inducing hypothermia and/or poikilothermia
CN205494095U (en) But automatically regulated's foreskin postoperative protector
CN205515068U (en) Modular foreskin postoperative protection pants
CN211560668U (en) Wound orthopedics binding device
CN218979363U (en) Knee pad device
CN212593421U (en) Local anesthesia device for anesthesia department
CN219594990U (en) Vulva protection applicator
CN205849668U (en) Neurosurgical nursing bracket

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20200727